BridgeMD
New treatment option for Hip Dysplasia
Official title Clinical Trial of Concomitant Hip Arthroscopy During PAO
ClinicalTrials.gov ID: NCT03181048
What this study is testing
- What it's testing
- The study will assess the outcomes of patients treated with concomitant hip arthroscopy at the time of periacetabular osteotomy (PAO) for patients with hip dysplasia compared with patients treated with PAO alone.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 55
You may be able to join if
- Diagnosis of hip dysplasia (DDH) electing periacetabular osteotomy (PAO) for treatment
- Skeletally mature
- Age 15 - 55
- Tonnis Grade 0 or 1 osteoarthritis (minimal or no arthritis)
- Ability to receive a standard of care preoperative (magnetic resonance imaging) MRI arthrogram of the hip
You likely can't join if
- Pregnant women
- Previous surgery about the hip
- Patients receiving PAO for acetabular retroversion in the absence of DDH
- Previous hip arthroscopy to address intra-articular pathology
The study team makes the final eligibility decision.
Where it's taking place
- Rochester, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rochester, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.